These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2547529)

  • 1. A phase II study of ifosfamide in the treatment of relapses in Wilms' tumor.
    Tournade MF
    Cancer Chemother Pharmacol; 1989; 24 Suppl 1():S31-3. PubMed ID: 2547529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ifosfamide is an active drug in Wilms' tumor: a phase II study conducted by the French Society of Pediatric Oncology.
    Tournade MF; Lemerle J; Brunat-Mentigny M; Bachelot C; Roche H; Taboureau O; Olive D; Lejars O; Boilletot A; Demeocq F
    J Clin Oncol; 1988 May; 6(5):793-6. PubMed ID: 2835442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ifosfamide, carboplatin and etoposide in children with poor-risk relapsed Wilms' tumor: a Children's Cancer Group report.
    Abu-Ghosh AM; Krailo MD; Goldman SC; Slack RS; Davenport V; Morris E; Laver JH; Reaman GH; Cairo MS
    Ann Oncol; 2002 Mar; 13(3):460-9. PubMed ID: 11996479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of ifosfamide as a single drug for relapsed paediatric patients.
    Schwartzman E; Scopinaro M; Angueyra N
    Cancer Chemother Pharmacol; 1989; 24 Suppl 1():S11-2. PubMed ID: 2503255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II study of ifosfamide in paediatric solid tumours.
    Pinkerton CR; Pritchard J
    Cancer Chemother Pharmacol; 1989; 24 Suppl 1():S13-5. PubMed ID: 2758566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ifosfamide in pediatric malignant solid tumors.
    Pratt CB; Douglass EC; Etcubanas EL; Goren MP; Green AA; Hayes FA; Horowitz ME; Meyer WH; Thompson EI; Wilimas JA
    Cancer Chemother Pharmacol; 1989; 24 Suppl 1():S24-7. PubMed ID: 2503257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rickets--a complication of ifosfamide chemotherapy for Wilms tumor.
    Relf M; Boal DK
    Pediatr Radiol; 1992; 22(3):209-10. PubMed ID: 1324461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refining therapeutic strategies for patients with resistant Wilm's tumor.
    Marina NM; Wilimas JA; Meyer WH; Jones DP; Douglass EC; Pratt CB
    Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):296-300. PubMed ID: 7978044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose ifosfamide with mesna uroprotection in Ewing's sarcoma.
    Jürgens H; Exner U; Kühl J; Ritter J; Treuner J; Weinel P; Winkler K; Göbel U
    Cancer Chemother Pharmacol; 1989; 24 Suppl 1():S40-4. PubMed ID: 2503258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etoposide in relapsed or refractory Wilms' tumor: a phase II study by the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study Group.
    Pein F; Pinkerton R; Tournade MF; Brunat-Mentigny M; Levitt G; Margueritte G; Rubie H; Sommelet D; Thyss A; Zücker JM
    J Clin Oncol; 1993 Aug; 11(8):1478-81. PubMed ID: 8393095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase 2 trial of ifosfamide/mesna as salvage therapy in patients with ovarian cancer refractory to or relapsing after prior platinum-containing chemotherapy.
    Sørensen P; Pfeiffer P; Bertelsen K
    Gynecol Oncol; 1995 Jan; 56(1):75-8. PubMed ID: 7821851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical studies of ifosfamide/mesna at St Jude Children's Research Hospital, 1983-1988.
    Pratt CB; Douglass EC; Etcubanas E; Goren MP; Green AA; Hayes FA; Horowitz ME; Meyer WH; Thompson EI; Wilimas JA
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):51-5. PubMed ID: 2495567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidoxorubicin plus ifosfamide in advanced and/or metastatic soft-tissue sarcomas.
    Toma S; Coialbu T; Biassoni L; Folco U; Gatti C; Canavese G; Giacchero A; Rosso R
    Cancer Chemother Pharmacol; 1990; 26(6):453-6. PubMed ID: 2121378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose ifosfamide with mesna uroprotection: a phase I study.
    Elias AD; Eder JP; Shea T; Begg CB; Frei E; Antman KH
    J Clin Oncol; 1990 Jan; 8(1):170-8. PubMed ID: 2104923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of carboplatin as a single drug for relapsed Wilms' tumor: experience of the Brazilian Wilms' Tumor Study Group.
    de Camargo B; Melaragno R; Saba e Silva N; Mendonça N; Alvares MN; Morinaka E; Marques A; Cusato MP
    Med Pediatr Oncol; 1994; 22(4):258-60. PubMed ID: 8107657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studies.
    Sutton GP; Blessing JA; Photopulos G; Berman ML; Homesley HD
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):68-72. PubMed ID: 2539647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ifosfamide-induced hyperpigmentation.
    Teresi ME; Murry DJ; Cornelius AS
    Cancer; 1993 May; 71(9):2873-5. PubMed ID: 8385568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topotecan is active against Wilms' tumor: results of a multi-institutional phase II study.
    Metzger ML; Stewart CF; Freeman BB; Billups CA; Hoffer FA; Wu J; Coppes MJ; Grant R; Chintagumpala M; Mullen EA; Alvarado C; Daw NC; Dome JS
    J Clin Oncol; 2007 Jul; 25(21):3130-6. PubMed ID: 17634492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ifosfamide with mesna in squamous carcinoma of the cervix: phase II results in patients with advanced or recurrent disease.
    Hannigan EV; Dinh TV; Doherty MG
    Gynecol Oncol; 1991 Nov; 43(2):123-8. PubMed ID: 1743553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral Wilms' tumors: a single-center experience with 19 cases.
    Millar AJ; Davidson A; Rode H; Numanoglu A; Hartley PS; Daubenton JD; Desai F
    J Pediatr Surg; 2005 Aug; 40(8):1289-94. PubMed ID: 16080934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.